Guardion Health Sciences Exhibiting at Caribbean Eye Meeting

Guardion Health Sciences Closes $5 Million Common Equity Financing

Guardion Health Sciences acquires VectorVision

Guardion Health Sciences announces completion of Series B funding round, raising over $3 million

International Carotenoid Society honors Advisory Board Members with Fellowship Awards

Guardion Health Sciences signs Letter of Intent to acquire VectorVision

Guardion Health Sciences, Inc. completes registration with SEC, becomes a Public Reporting Company

Guardion Health Sciences Medical Advisory Board Member Receives Prestigious Award For Excellence In Ophthalmology Research And Service

Guardion Health Sciences receives patent for its diagnostic device, the MapcatSF

P Dee G Stephenson, M.D. joins Guardion Health Sciences Medical Advisory Board

Bridgitte Shen Lee, O.D. joins Guardion Health Sciences Medical Advisory Board

Guardion Health Sciences Files Form S-1 Registration Statement under the Securities Act of 1933

Macular pigment specialists, Guardion Health Sciences appoints Gordon Bethwaite as Vice President

Col (R) Donald A. Gagliano, MD, MHA, FACHE, CPC joins Guardion’s Science Advisory Board

Macular Carotenoids Conference 2013

Professors Bone and Landrum honored at the Macular Carotenoids & AMD Conference 2011 in Cambridge, UK.

GHS Scientists to Present at the Macular Carotenoids & AMD Conference 2011

March 2011. Review of Ophthalmology – Targeting AMD with a Critical Carotenoid

October 2010. Review of Ophthalmology – The Role of Nutritional Therapies in Preventing Macular Degeneration